Munksgaard Chang (pulllatex5)

Candida auris is identified as an emerging pathogen worldwide. It is multidrug resistant and causes invasive healthcare-associated infections. Our retrospective study was conducted to determine the prevalence and epidemiology of C. auris infections in a tertiary care hospital in Jaipur.24 clinical C. auris strains were included, most being from urine. Deoxycholic acid sodium price The majority patients needed intensive care and had at least one underlying co-morbid condition. A history of broad-spectrum antibiotic or antifungal usage was present in 85%. Fluconazole, voriconazole, amphotericin B and 5-fluorocytosine resistance was seen in 96, 42, 33 and 8% isolates respectively. No echinocandin resistance was noted.Uric acid is a metabolic product of nucleic acid and protein. Hyperuricemia results from failure or lack of urate oxidase. We present a case of a 61-year-old man with a painless forearm swelling, from which uric acid crystals were found on cytology. There were also septate fungal hyphae with morphology of Aspergillus, which has the source of the uric acid. Serum uric acid levels in our patient were normal.Norway, where a majority of new cars sold are currently electric, has emerged as a rich location for studying transitions towards electric mobility. Such transitions have often been conceptualized through a Multi-Level Perspective (MLP), which generally designates the technology as a disruptive niche with potential to upend the obdurate and problematic automobilty regime. Drawing upon Actor-Network Theory (ANT), this article re-examines this designation and provides nuance to theories of sustainable transition. This change in perspective enable us to re-centre user practices and investigate how electric vehicle drivers operate within complex human/non-human networks. Rather than viewing stability and change as the result of interactions between pre-determined levels, ANT allows us to explore how stability and change is co-produced in a multitude of locations. Drawing upon qualitative interview data, the article finds that new configurations of users and technology are currently emerging, elucidating dynamics of sociotechnical change, while cultural and geographical barriers to more radical mobility shifts are equally pronounced. As such, electric mobility currently finds itself between reinforcing the automobility system, while also engendering exciting new associations between drivers, cars and the world outside the windshield.Veterinarians diagnose marijuana toxicity based on clinical signs and history, or in conjunction with an over-the-counter (OTC) human urine drug screen. With the legalization of recreational marijuana use becoming more prevalent in the United States, a more accurate test to aid in the diagnosis of canine marijuana toxicity is needed. We collected urine and serum samples from 19 dogs with confirmed or suspected marijuana toxicosis from multiple veterinary hospitals and analyzed them with a novel UPLC-MS/MS method. Calibrations from 0.1 to 100 ng/mL and QC materials were prepared. Samples were extracted, purified, and eluted with solid-phase extraction. Urine samples were tested with an OTC human urine drug screen. The limit of detection (LOD) and lower limit of quantification (LLOQ) ranges for marijuana metabolites in serum were 0.05-0.25 ng/mL and 0.1-0.5 ng/mL, respectively. In urine, the LOD and LLOQ ranges for the metabolites were 0.05-0.1 ng/mL and 0.1-0.5 ng/mL, respectively. In serum, median and range of metabolite concentrations (ng/mL) detected included THC, 65.0 (0.14-160); 11-OH-Δ9-THC, 4.78 (1.15-17.8); 11-nor-9-carboxy-Δ9-THC, 2.18 (0.71-7.79); CBD, 0.28 (0.11-82.5); and THC-glucuronide, 2.05 (0.72-18.3). In the 19 urine samples, metabolite creatinine (ng mg) values detected included THC, 0.22 (0.05-0.74); 11-OH-Δ9-THC, 0; 11-nor-9-carboxy-Δ9-THC, 1.32 (0.16-11.2); CBD, 0.19 (0.12-0.26); THC-COOH-glucuronide, 0.08 (0.04-0.11); and THC-glucuronide, 0.98 (0.25-10.7). Twenty of 2